MediWound Ltd. - Ordinary Shares (NQ:MDWD)

13.38 -0.47 (-3.43%)

Delayed Quote Updated: 3:39 PM EDT, Oct 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about MediWound Ltd. - Ordinary Shares

< Previous 1 2 3 4 5 6 7 Next >

MediWound Announces Closing of the Concurrent Registered Direct and Private Placement Offerings

October 07, 2022

Gross Proceeds of $30.5 Million Raised

From MediWound Ltd.

Via GlobeNewswire

Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday ↗

September 23, 2022

Gainers

Via Benzinga

Recap: MediWound Q2 Earnings ↗

August 09, 2022

MediWound (NASDAQ:MDWD) reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Dow Turns Higher; Crude Oil Rises 0.7% ↗

September 22, 2022

U.S. stocks pared some losses, with the Dow Jones turning higher toward the end of trading on Thursday.

Via Benzinga

Why MediWound Is Trading Lower By Around 18%, Here Are 48 Stocks Moving In Thursday's Mid-Day Session ↗

September 22, 2022

Gainers

Via Benzinga

Nasdaq Drops Over 100 Points; Spero Therapeutics Shares Spike Higher ↗

September 22, 2022

U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 100 points on Thursday.

Via Benzinga

MediWound Posts Early Data From Non-Melanoma Skin Cancer Trial ↗

July 11, 2022

Via Benzinga

MediWound's EscharEx Shows Safe, Effective, Rapid Debridement Of Leg Ulcers ↗

July 07, 2022

Via Benzinga

MediWound: Q1 Earnings Insights ↗

May 17, 2022

MediWound (NASDAQ:MDWD) reported its Q1 earnings results on Tuesday, May 17, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary ↗

August 03, 2022

Via Benzinga

FDA Accepts MediWound's Refiling For Severe Thermal Burns Therapy For Review ↗

August 03, 2022

The U.S. Food and Drug Administration (FDA) has accepted for review MediWound’s (NASDAQ: MDWD) recently re-submitted Biologics License Application (BLA) for its lead asset NexoBrid for eschar removal...

Via Benzinga

The Daily Biotech Pulse: Pfizer-BioNTech's COVID-19 Booster For Kids 5-11 Coming Soon, Ultragenyx In-Licenses Gene Therapy For Genetic Disorder, Ampio's AP-013 Trial Under Independent Investigation ↗

May 17, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Earnings Scheduled For May 17, 2022 ↗

May 17, 2022

Companies Reporting Before The Bell • On Holding (NYSE:ONON) is likely to report earnings for its first quarter.

Via Benzinga

MediWound: Q4 Earnings Insights ↗

March 17, 2022

MediWound (NASDAQ:MDWD) reported its Q4 earnings results on Thursday, March 17, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

Preview: MediWound's Earnings ↗

May 16, 2022

MediWound (NASDAQ:MDWD) is set to give its latest quarterly earnings report on Tuesday, 2022-05-17. Here's what investors need to know before the announcement. Analysts estimate that MediWound will...

Via Benzinga

The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More ↗

May 16, 2022

Biopharma stocks remained largely unchanged in the week ending May 13, with the defensive nature of the sector coming to its aid. Stocks reacted to the broader market move and earnings news from...

Via Benzinga

The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And More ↗

May 12, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

MediWound Earnings Preview ↗

March 16, 2022

MediWound (NASDAQ:MDWD) is set to give its latest quarterly earnings report on Thursday, 2022-03-17. Here's what investors need to know before the announcement. Analysts estimate...

Via Benzinga

MediWound Posts Promising EscharEx Data For Chronic Wounds ↗

May 12, 2022

MediWound Ltd (NASDAQ: MDWD) has announced results from its U.S. Phase 2 clinical study of EscharEx for the debridement of venous leg ulcers (VLUs).

Via Benzinga

The Daily Biotech Pulse: AbbVie's Rinvoq Gets Label Expansion, AstraZeneca COVID Antibody Cocktail Authorized By UK Regulator, Stealth Touts Positive Data ↗

March 17, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

36 Stocks Moving In Thursday's Mid-Day Session ↗

March 03, 2022

Gainers Indonesia Energy Corporation Limited (NASDAQ: INDO) shares jumped 46% to $21.13 after jumping around 35% on Wednesday. Eos Energy Enterprises, Inc. (NASDAQ: EOSE...

Via Benzinga

Earnings Scheduled For March 17, 2022 ↗

March 17, 2022

Companies Reporting Before The Bell • TransGlobe Energy (NASDAQ:TGA) is estimated to report earnings for its fourth quarter. • Ikena Oncology (NASDAQ:IKNA) is...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

March 03, 2022

Good morning! In preparation for another busy day of trading, we've put together a list of the biggest pre-market stock movers for Thursday!

Via InvestorPlace

63 Biggest Movers From Yesterday ↗

March 04, 2022

Gainers Indonesia Energy Corporation Limited (NASDAQ: INDO) shares climbed 39.3% to close at $20.20 on Thursday after jumping around 35% on Wednesday. DBV Technologies S.A. (...

Via Benzinga

MediWound Receives Additional $9M From BARDA For NexoBrid FDA Application Resubmission ↗

February 10, 2022

The Biomedical Advanced Research and Development Authority (BARDA) will

Via Benzinga

The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly ↗

February 10, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

MediWound's EscharEx Mid-Stage Trial Meets Primary Goal In Venous Leg Ulcers ↗

January 24, 2022

MediWound Ltd (NASDAQ: MDWD) has posted topline results from its U.S. Phase 2 study of EscharEx for the debridement (removal of dead or infected skin tissue for...

Via Benzinga

The Daily Biotech Pulse: Kezar Jumps On Data, Biogen R&D Chief To Retire, Molecular Partners Wilts On COVID Trial Disappointment ↗

November 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Kezar Life Sciences Reports Positive Interim Phase 2 Data For Lupus Nephritis...

Via Benzinga

Earnings Scheduled For November 16, 2021 ↗

November 16, 2021

Companies Reporting Before The Bell • Ozon Holdings (NASDAQ:OZON) is expected to report quarterly loss at $0.90 per share on revenue of $602.00 million. • Sea (...

Via Benzinga

Earnings Preview For MediWound ↗

November 15, 2021

MediWound (NASDAQ:MDWD) is set to give its latest quarterly earnings report on Tuesday, 2021-11-16. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.